Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,265
archived clinical trials in
Crohns Disease

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Rx Trials
mi
from
Washington,
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Rx Trials
mi
from
Washington,
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Venture Research
mi
from
N. Miami Beach, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Venture Research
mi
from
N. Miami Beach, FL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Visions Clinical Research - Sarasota
mi
from
Sarasota, FL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Visions Clinical Research - Sarasota
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Pinnacle Trials
mi
from
Atlanta, GA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Pinnacle Trials
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Saint Joseph's Health System, Inc.
mi
from
Atlanta, GA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Saint Joseph's Health System, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Northwestern University School of Medicine
mi
from
Chicago, IL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Northwestern University School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
University of Chicago
mi
from
Chicago, IL
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
University of Louisville
mi
from
Louisville, KY
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Asher Kornbluth, MD PC
mi
from
New York, NY
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Asher Kornbluth, MD PC
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Allegheny General Hospital-Allegheny Ctr for Digestive Diseases
mi
from
Pittsburg, PA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Allegheny General Hospital-Allegheny Ctr for Digestive Diseases
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Methodist Hospital/Baylor University
mi
from
Houston, TX
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Methodist Hospital/Baylor University
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
University of Utah
mi
from
Salt Lake City, UT
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Mcguire Dvamc
mi
from
Richmond, VA
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Mcguire Dvamc
mi
from
Richmond, VA
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Dean Foundation Research Center
mi
from
Madison, WI
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Dean Foundation Research Center
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated:  11/10/2015
Vancouver General Hospital
mi
from
Vancouver,
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease
Status: Enrolling
Updated: 11/10/2015
Vancouver General Hospital
mi
from
Vancouver,
Click here to add this to my saved trials
Comparative Effectiveness of MR Enterography
Comparative Effectiveness of MR Enterography, Enteric Ultrasound, and Ultrasound Elastography Imaging in the Evaluation of Pediatric Small Bowel Crohn Disease
Status: Enrolling
Updated:  12/7/2015
University of Michigan
mi
from
Ann Arbor, MI
Comparative Effectiveness of MR Enterography
Comparative Effectiveness of MR Enterography, Enteric Ultrasound, and Ultrasound Elastography Imaging in the Evaluation of Pediatric Small Bowel Crohn Disease
Status: Enrolling
Updated: 12/7/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease
NIH SUBSTUDY:Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of Two Single Infusions of AIN457 in Patients With Moderate to Severe Active Crohn's Disease
Status: Enrolling
Updated:  12/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease
NIH SUBSTUDY:Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of Two Single Infusions of AIN457 in Patients With Moderate to Severe Active Crohn's Disease
Status: Enrolling
Updated: 12/7/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
UAB Hospital
mi
from
Birmingham, AL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
UAB Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Simon Medical Imaging
mi
from
Scottsdale, AZ
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Simon Medical Imaging
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Digestive Health Research Unit
mi
from
Scottsdale, AZ
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Digestive Health Research Unit
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Adobe Clinical Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Radiology Ltd
mi
from
Tucson, AZ
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Radiology Ltd
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
UCSF Endoscopy Unit at Mount Zion
mi
from
San Francisco, CA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
UCSF Endoscopy Unit at Mount Zion
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
University of California at San Francisco
mi
from
San Francisco, CA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
University of California, San Francisco - Mount Zion
mi
from
San Francisco, CA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
University of California, San Francisco - Mount Zion
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Rocky Mountain Clinical Research, LLC
mi
from
Denver, CO
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Rocky Mountain Clinical Research, LLC
mi
from
Denver, CO
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Rocky Mountain Gastroenterology Associates
mi
from
Lakewood, CO
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Rocky Mountain Gastroenterology Associates
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Arapahoe Gastroenterology
mi
from
Littleton, CO
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Arapahoe Gastroenterology
mi
from
Littleton, CO
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Endoscopy Center of Connecticut, LLC
mi
from
Guilford, CT
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Endoscopy Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Gastroenterology Center of Connecticut
mi
from
Hamden, CT
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Gastroenterology Center of Connecticut
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Medical Research Center of Connecticut, LLC
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Clinical Research of West Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Gastroenterology Associates
mi
from
Crystal River, FL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Gastroenterology Associates
mi
from
Crystal River, FL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Suncoast Endoscopy Center
mi
from
Inverness, FL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Suncoast Endoscopy Center
mi
from
Inverness, FL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Advanced Research Institute, Inc
mi
from
New Port Richey, FL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Advanced Research Institute, Inc
mi
from
New Port Richey, FL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
International Clinical Research - US, LLC
mi
from
Sanford, FL
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
International Clinical Research - US, LLC
mi
from
Sanford, FL
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Atlanta Center for Gastroenterology, P.C.
mi
from
Decatur, GA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Atlanta Center for Gastroenterology, P.C.
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Atlanta Endoscopy Center
mi
from
Decatur, GA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Atlanta Endoscopy Center
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Decatur Health Imaging
mi
from
Decatur, GA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Decatur Health Imaging
mi
from
Decatur, GA
Click here to add this to my saved trials
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated:  12/14/2015
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Crohn's Disease Who Are Anti-tnf Inadequate Responders (Andante)
Status: Enrolling
Updated: 12/14/2015
Gastrointestinal Specialists of Georgia
mi
from
Marietta, GA
Click here to add this to my saved trials